"A positive test for a rare disease usually doesn't mean what you think. The math is simple; the citizen panic is universal."
The Setup
Suppose a disease affects 1 in 1,000 people in a population. A test for the disease has 99% sensitivity (P(positive | disease) = 0.99) and 95% specificity (P(negative | healthy) = 0.95, so the false-positive rate is 5%). You test positive. The citizen instinct: 'the test is 99% accurate, so I almost certainly have it.' The Bayesian answer: about 2%.
The Calculation
Imagine 100,000 people from the population. About 100 have the disease; about 99,900 do not. Apply the test:
- 99 of the 100 sick are correctly positive (99% sensitivity).
- ~4,995 of the 99,900 healthy are falsely positive (5% false-positive rate).
Total positives: ~5,094. Of those, only 99 are actually sick. P(sick | positive) ≈ 99 / 5,094 ≈ 1.94%. Not 99%. About 2%.
The arithmetic is straightforward. The reason citizens get it wrong is they confuse sensitivity (P(positive | sick)) with posterior (P(sick | positive)). The two are conditional probabilities in opposite directions, related by Bayes' rule and the prior.
Why This Matters in the Clinic
Screening policy weighs benefits and harms across age, risk, test performance, follow-up, and treatment—not base rates alone. Current U.S. Preventive Services Task Force guidance recommends biennial breast-cancer screening for women aged 40 to 74, with individual assessment outside that range, and HIV screening for adolescents and adults aged 15 to 65 plus younger or older people at increased risk.
A screening recommendation is a population-level benefit–harm judgment, not a personal diagnosis and not simply a Bayesian calculation. A positive screen usually requires confirmatory evaluation.